Biliary Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-07-28
EMA Authorised: Iqirvo (Elafibranor) — Ipsen Pharma
The EMA authorised Iqirvo (elafibranor) for liver cirrhosis and biliary diseases with conditional approval, and it has orphan medicine desig…